| PaulKing 2004-12-30, 10:06 pm |
| FOUR GRADE EVENT
By Celia Farber, in the New York Press:
http://www.nypress.com/17/52/news&c...celiafarber.cfm
Let us not forget that Nevirapine is a drug that was pulled by its own
manufacturer from use in the West, after an investment of many millions of
dollars. It remains banned for use in pregnant
first-world women.
Still, the NIH is using it on American women, in experimental trials you
never heard about-until now. Alongside the revelations about the Ugandan
trial, the AP stories brought to light that Joyce Ann Hafford, a
33-year-old, perfectly healthy, eight-months pregnant HIV-positive woman
from Tennessee died from liver failure in an NIH trial testing Nevirapine.
Her liver counts had been way off for days, and still doctors didn't take
her off the drug.
The doctors told her family, naturally, that she had died of AIDS.
The trouble is, cocktail-drug deaths are easily distinguished from AIDS
deaths. This was not the case with AZT, a drug that simply decimated the
immune system. Cocktail deaths are caused primarily by liver toxicity,
heart attacks and strokes-from the effects of the drugs on the body's fat
metabolism.
Hafford's death crystallizes the raging conflict between the establishment
point of view that HIV is deadly and drugs save lives and the "denialist"
or dissident point of view that HIV is not deadly at all by itself, but
AIDS drugs are. Hafford had no so-called AIDS symptoms; she was simply
HIV
positive. She also had an older healthy child, which suggests that HIV may
not be as lethal as advertised.
By refusing to lament her death, or even the
scores of Ugandan deaths, and instead attacking the messenger, the AIDS
establishment has shown itself to be lost, with a broken compass, on the
map of medicinal ethics.
Once it becomes acceptable to kill patients in experimental clinical
trials and cover it up, without consequence, you might argue that all is
lost.
|